These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27861140)

  • 1. Non-alcoholic fatty liver disease in children and adolescents.
    Penke M; Kiess W; Giorgis T
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1329-1330. PubMed ID: 27861140
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease.
    Pearce L
    Nurs Stand; 2016 Aug; 30(52):15. PubMed ID: 27641564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].
    Ströhle A; Stein J
    Med Monatsschr Pharm; 2015 May; 38(5):166-78; quiz 179-80. PubMed ID: 26364406
    [No Abstract]   [Full Text] [Related]  

  • 6. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.
    Eng K; Lopez R; Liccardo D; Nobili V; Alkhouri N
    Dig Liver Dis; 2014 Nov; 46(11):1008-13. PubMed ID: 25106814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.
    Giorgio V; Miele L; Principessa L; Ferretti F; Villa MP; Negro V; Grieco A; Alisi A; Nobili V
    Dig Liver Dis; 2014 Jun; 46(6):556-60. PubMed ID: 24631029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and diabetes.
    Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P
    Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutting out the liver fat.
    Nat Med; 2017 Dec; 23(12):1385. PubMed ID: 29216035
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioenergetic remodeling in the pathophysiology and treatment of nonalcoholic fatty liver disease.
    Azul AM; Winter M; Silva D; Georgievska L; Oliveira PJ
    Eur J Clin Invest; 2022 Mar; 52(3):e13749. PubMed ID: 35156207
    [No Abstract]   [Full Text] [Related]  

  • 12. Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?
    Verduci E; Lassandro C; Radaelli G; Soldati L
    J Transl Med; 2015 Apr; 13():109. PubMed ID: 25889212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease in HIV Infection.
    Macías J; Pineda JA; Real LM
    AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.
    Yari Z; Rahimlou M; Eslamparast T; Ebrahimi-Daryani N; Poustchi H; Hekmatdoost A
    Int J Food Sci Nutr; 2016 Jun; 67(4):461-9. PubMed ID: 26983396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.
    Temple JL; Cordero P; Li J; Nguyen V; Oben JA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.
    Chou CY; Yang YC; Wu JS; Sun ZJ; Lu FH; Chang CJ
    Diab Vasc Dis Res; 2015 Sep; 12(5):359-65. PubMed ID: 26008803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of exercise for patients with non-alcoholic fatty liver disease.
    Keating SE; George J; Johnson NA
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.